FDA-Approved Prostate Cancer Treatments
Approved prostate cancer drug treatments including formulations and usual dosing.
Oncology
FDA-Approved Non-Small Cell Lung Cancer (NSCLC) Treatments
Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).
Antiemetic Treatments
Antiemetic treatment chart including drug formulations, strengths, and usual doses for nausea/vomiting.
FDA-Approved Breast Cancer Treatments
FDA-approved oral and injectable treatment options for breast cancer.
Cancer Risk From Recalled ARBs “Likely Much Lower” Than Initially Estimated, Says FDA
The FDA is working in close collaboration with global regulatory partners to evaluate the controls in place and publish guidance on preventing unacceptable levels of nitrosamine in drugs.
Biosimilars Mvasi, Kanjinti Now Available in the US
Biosimilars Mvasi and Kanjinti are now available in the United States.
FDA Approves Novel Therapy for Relapsed, Refractory Multiple Myeloma
Continued approval of Xpovio for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Daratumumab Gets Approval for Additional Multiple Myeloma Indication
The FDA has expanded the approval of Darzalex (daratumumab; Janssen Biotech) to include use in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.
US Incidence of Pediatric Thyroid Cancer on the Rise
More marked increases in incidence observed from 2006 to 2013 than from 1973 to 2006.
Next post in Uncategorized
